Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Life Pain Specialists (LPS) With a Focus on Patient Pain Management and Prevention of Substance Misuse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04154384
Recruitment Status : Enrolling by invitation
First Posted : November 6, 2019
Last Update Posted : November 14, 2019
Sponsor:
Collaborator:
Christopher Wolf Crusade (CWC)
Information provided by (Responsible Party):
Mara Schenker, Emory University

Brief Summary:
This is a pilot, single-center study where the Life Pain Specialist (LPS) will provide personalized Patient Pain Plan (PPP) to patients combating pain. LPS assessments will focus on the level of risk the patient has for potential substance misuse and the Pain Plans will be unique to each patient. Participants will be followed for one year post operation.

Condition or disease Intervention/treatment Phase
Opioid Use Behavioral: Patient Pain Plan (PPP) Not Applicable

Detailed Description:

Opioids are psychoactive substances (narcotics) primarily used for pain relief by producing morphine-like effects. Although regularly prescribed by physicians, opioids (including morphine, codeine, and oxycodone) are highly addictive. Opioids block feelings of pain and trigger a release of dopamine. Dependence occurs with repeated use, as the parts of the brain naturally responsible for releasing dopamine rely on the drug for proper function. When avoided, patients quickly experience severe withdrawal symptoms similar to the flu.

In the United States, millions are prescribed opioids for pain relief. Every day, more than 115 people die from overdose. The highest among them are people aged 25 to 54 years. Addiction treatment costs near $78.5 billion and rising, less than 10% of people in need are receiving it.

Within the orthopaedic trauma population at Grady Healthcare in Atlanta, Georgia, 20% of patients report a history of substance abuse, 30% have previously used opioid medications for pain, and nearly 25% report taking opioid pain medications up to 1 year after their trauma. Trauma patients are particularly at high risk.

The Christopher Wolf Crusade (CWC) is a 501C3 non-profit providing preventative solutions, education, and advocacy for the American opioid epidemic. CWC's primary focus is to introduce a behavior-specific intervention at the time of inpatient hospitalization for trauma to decrease overall opioid utilization and improve pain control in the post-trauma time period. The goal of this study is to introduce Life Pain Specialists (LPS) to the healthcare field to focus on pain management and addiction prevention for patients. The LPS is a behavior-based pain "coach" who educates patients on risks of opioid dependence and offers non-traditional non-pharmacologic options for pain control. In addition, the LPS will act as a liaison between the patient and the physician to ensure that traditional pharmacologic-based pain control regimens are optimized.

Potential patients will be identified during their initial presentation to Grady Hospital during morning trauma board rounds within the first 24 hours of admission. Once the consent process is complete, the participants will be referred to the LPS team. Participants will be followed in the orthopaedic trauma clinic at routine post-operative intervals (2 weeks, 6 weeks, 3 months, 6 months, and 1 year post-operatively).


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Life Pain Specialists (LPS) With a Focus on Patient Pain Management and Prevention of Substance Misuse
Estimated Study Start Date : November 2019
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : September 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Patient Pain Plan (PPP)
Orthopedic trauma patients will work with a Life Pain Specialist (LPS) and will receive a personalized Patient Pain Plan (PPP) to avoid potential opioid misuse.
Behavioral: Patient Pain Plan (PPP)
The Life Pain Specialist (LPS) will work with the patient to develop a Patient Pain Plan (PPP) focused on behavioral education, and will act as a liaison with physicians to optimize the pharmacologic component of pain management. The PPP includes education about substance misuse and provides non-pharmacological pain management options.




Primary Outcome Measures :
  1. Opioid Pain Medication Usage [ Time Frame: Month 12 ]
    The primary outcome of the study will be the utilization of opioid pain medication at 1 year after the operation. This value will be compared to the 23% of a historical control cohort reporting continuing to use opioids a year post operation.


Secondary Outcome Measures :
  1. Change in Pain Score [ Time Frame: Week 2, Week 6, Month 3, Month 6, Month 12 ]
    Pain will be assessed using an 11-point Likert scale where 0 = no pain and 10 = severe pain.

  2. Change in Opioid Utilization [ Time Frame: Day 1 (at hospital discharge), Week 2, Week 6 ]
    Opioid utilization will be recorded in morphine equivalents.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Orthopaedic trauma patients with planned operative fixation of one or more fractures
  • Informed consent obtained

Exclusion Criteria:

  • Patients that did not undergo operative fixation of one or more fractures
  • Incarceration
  • Enrolled in a study that does not permit co-enrollment
  • Unlikely to comply with the follow-up schedule
  • Unable to converse, read or write English at elementary school level

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04154384


Locations
Layout table for location information
United States, Georgia
Grady Health System
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Christopher Wolf Crusade (CWC)
Investigators
Layout table for investigator information
Principal Investigator: Mara Schenker, MD Emory University

Layout table for additonal information
Responsible Party: Mara Schenker, Assistant Professor, Emory University
ClinicalTrials.gov Identifier: NCT04154384     History of Changes
Other Study ID Numbers: IRB00115061
First Posted: November 6, 2019    Key Record Dates
Last Update Posted: November 14, 2019
Last Verified: November 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mara Schenker, Emory University:
Orthopedic surgery
Opioid addiction
Rehabilitation
Behavioral research